Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA.
AMIA Annu Symp Proc. 2021 Jan 25;2020:1022-1030. eCollection 2020.
Brigham and Women's Hospital (BWH) has received funding from the Centers for Medicare and Medicaid Services (CMS) to design and implement an electronic clinical quality measure (eCQM) assessing the rate of prolonged opioid prescribing practices following Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA). Utilizing an existing guideline, 'prolonged prescribing' has been defined as opioid prescriptions that exceed 42 days (6 weeks) following surgery. This measure was tested on 12,803 Partners' Healthcare (PHS) patients. Findings demonstrated that after 42 days, meeting the criteria for 'prolonged prescribing' as defined by the proposed measure, 3.7% of THA patients and 12.1% of TKA patients were still receiving opioids. With a better understanding of how specific clinician group post-operative prescribing practices compare with their peers and incorporating monetary incentives through the MIPS participation pathway of the Quality Payment Program (QPP), this measure will motivate orthopedic practices to improve their prescribing patterns, ultimately driving evidence-based quality improvement.
布莱根妇女医院 (BWH) 已获得医疗保险和医疗补助服务中心 (CMS) 的资助,用于设计和实施一项电子临床质量衡量标准 (eCQM),以评估全髋关节置换术 (THA) 和全膝关节置换术 (TKA) 后延长阿片类药物处方的比例。利用现有的指南,“延长处方”被定义为手术后超过 42 天(6 周)的阿片类药物处方。该措施已在 12803 名合作伙伴医疗保健 (PHS) 患者中进行了测试。研究结果表明,在 42 天后,根据拟议措施定义的“延长处方”标准,3.7%的 THA 患者和 12.1%的 TKA 患者仍在接受阿片类药物治疗。通过质量支付计划 (QPP) 的 MIPS 参与途径,更好地了解特定临床医生群体的术后处方实践如何与其同行进行比较,并提供货币激励,这一措施将激励骨科实践改进其处方模式,最终推动循证质量改进。